US Biosimilars Market: AmerisourceBergen Q&A

Generics Bulletin |

Incentives for uptake, physician education, legal barriers and patient services are among the issues covered in a wide-ranging question-and-answer session conducted with Sean McGowan, senior director of biosimilars at AmerisourceBergen.

For the full story, check out Generics Bulletin.